{'text': 'Alirocumab reduced LDL cholesterol according to new results', 'publisher': {'href': 'https://www.europeanpharmaceuticalreview.com', 'title': 'European Pharmaceutical Review'}, 'created_at': 'Wed, 19 Nov 2014 08:00:00 GMT', 'description': 'Alirocumab reduced LDL cholesterol according to new results  European Pharmaceutical Review', 'url': 'https://news.google.com/rss/articles/CBMi_wFBVV95cUxPM1huN1hyOUxRelBLUllmbFc1cUJiTGxuZmk5WmY1N2l2RTItQkFacEhTTkpjVWFCRkxFMHNGRmdwaEdVNFR0UVZsMGR5QkxZTGM1QlpDYVg5VWJ3T0pWTmthVGZ2NXFoRThVMTk5YXExOWw0emQtUWlyQm1OTXdJaFhLcUlFOGtrQnZBSkNGVEFMaG15YmdMdGE5T2dMc2lrck9CMk9aMEJrd3ItTFlXNEYwUHdtaXZUSTRaczRzbU1SNmY3QVBSTm1ZTGZ2RkZuakdaVHo2Um1DcV9OMUdFUlVUdlVsZjhfTjhNUlU1QmtaRnZBTkRENDJGQWhfaFk?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'AZ seeks leg up in antiplatelet market with Brilinta antidote', 'publisher': {'href': 'https://pmlive.com', 'title': 'PMLiVE'}, 'created_at': 'Wed, 19 Nov 2014 08:00:00 GMT', 'description': 'AZ seeks leg up in antiplatelet market with Brilinta antidote  PMLiVE', 'url': 'https://news.google.com/rss/articles/CBMiogFBVV95cUxPZl8yWVZYNm01cTIzX18xQU1MSkpUdVkxdkxTN3ZyMGllUGt3eWtRcmxSTDlFYlRSaVFVOS1UbEZFdERhLU5IZDNLNlVmcXBCcDVMYVZTbndHTGlaWEpxRzdFblZYRDNneGpMZmZib09oVk1qZDJ2LWxBbThHM3lNdXl6Ymdid1RKMkVtblRuV1JtZm9RMjEwVW5Oc1FWTllkVmc?oc=5&hl=en-US&gl=US&ceid=US:en'}
